Influenza vaccines: A review and rationale for use in developed and underdeveloped countries

Gregory A. Poland, Scott T. Rottinghaus, Robert M. Jacobson

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Multiple studies have demonstrated that influenza infection results in considerable morbidity and mortality, as well as other economic consequences, such as school and work absenteeism. Influenza vaccine has been shown to be both cost-effective and cost-saving. Despite this, the influenza vaccine appears to be under-utilized throughout the world, with significant variations both between countries and within countries over time. Data will be discussed that provide a rationale for the use of the influenza vaccine to protect the public health. Recommendations for the use of the influenza vaccine in various countries and guidelines for influenza vaccine use worldwide will be proposed.

Original languageEnglish (US)
Pages (from-to)2216-2220
Number of pages5
JournalVaccine
Volume19
Issue number17-19
DOIs
StatePublished - Mar 21 2001

Fingerprint

Influenza Vaccines
Developed Countries
developed countries
influenza
developing countries
vaccines
Costs and Cost Analysis
Absenteeism
Human Influenza
cost effectiveness
Public Health
morbidity
Economics
Guidelines
public health
Morbidity
Mortality
economics
Infection
infection

Keywords

  • Influenza
  • Influenza vaccine
  • Vaccine coverage
  • Vaccine policy

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Influenza vaccines : A review and rationale for use in developed and underdeveloped countries. / Poland, Gregory A.; Rottinghaus, Scott T.; Jacobson, Robert M.

In: Vaccine, Vol. 19, No. 17-19, 21.03.2001, p. 2216-2220.

Research output: Contribution to journalArticle

Poland, Gregory A. ; Rottinghaus, Scott T. ; Jacobson, Robert M. / Influenza vaccines : A review and rationale for use in developed and underdeveloped countries. In: Vaccine. 2001 ; Vol. 19, No. 17-19. pp. 2216-2220.
@article{74aa980efe084297a855a90c5268ca83,
title = "Influenza vaccines: A review and rationale for use in developed and underdeveloped countries",
abstract = "Multiple studies have demonstrated that influenza infection results in considerable morbidity and mortality, as well as other economic consequences, such as school and work absenteeism. Influenza vaccine has been shown to be both cost-effective and cost-saving. Despite this, the influenza vaccine appears to be under-utilized throughout the world, with significant variations both between countries and within countries over time. Data will be discussed that provide a rationale for the use of the influenza vaccine to protect the public health. Recommendations for the use of the influenza vaccine in various countries and guidelines for influenza vaccine use worldwide will be proposed.",
keywords = "Influenza, Influenza vaccine, Vaccine coverage, Vaccine policy",
author = "Poland, {Gregory A.} and Rottinghaus, {Scott T.} and Jacobson, {Robert M.}",
year = "2001",
month = "3",
day = "21",
doi = "10.1016/S0264-410X(00)00448-5",
language = "English (US)",
volume = "19",
pages = "2216--2220",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "17-19",

}

TY - JOUR

T1 - Influenza vaccines

T2 - A review and rationale for use in developed and underdeveloped countries

AU - Poland, Gregory A.

AU - Rottinghaus, Scott T.

AU - Jacobson, Robert M.

PY - 2001/3/21

Y1 - 2001/3/21

N2 - Multiple studies have demonstrated that influenza infection results in considerable morbidity and mortality, as well as other economic consequences, such as school and work absenteeism. Influenza vaccine has been shown to be both cost-effective and cost-saving. Despite this, the influenza vaccine appears to be under-utilized throughout the world, with significant variations both between countries and within countries over time. Data will be discussed that provide a rationale for the use of the influenza vaccine to protect the public health. Recommendations for the use of the influenza vaccine in various countries and guidelines for influenza vaccine use worldwide will be proposed.

AB - Multiple studies have demonstrated that influenza infection results in considerable morbidity and mortality, as well as other economic consequences, such as school and work absenteeism. Influenza vaccine has been shown to be both cost-effective and cost-saving. Despite this, the influenza vaccine appears to be under-utilized throughout the world, with significant variations both between countries and within countries over time. Data will be discussed that provide a rationale for the use of the influenza vaccine to protect the public health. Recommendations for the use of the influenza vaccine in various countries and guidelines for influenza vaccine use worldwide will be proposed.

KW - Influenza

KW - Influenza vaccine

KW - Vaccine coverage

KW - Vaccine policy

UR - http://www.scopus.com/inward/record.url?scp=0035925678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035925678&partnerID=8YFLogxK

U2 - 10.1016/S0264-410X(00)00448-5

DO - 10.1016/S0264-410X(00)00448-5

M3 - Article

C2 - 11257336

AN - SCOPUS:0035925678

VL - 19

SP - 2216

EP - 2220

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 17-19

ER -